Dollar Amounts
USD (Millions)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Assets | $2,263 | $2,295 | $2,639 | $2,704 | $2,558 |
| Liabilities | $700 | $593 | $672 | $635 | $639 |
| Equity | $1,563 | $1,702 | $1,967 | $2,069 | $1,919 |
Balance sheet data in USD (millions)
Doing some research...
Edwyn
Over the past 5 years, BIO-TECHNE Corp has exhibited a consistent growth trajectory in terms of its financial position. Total assets have shown a steady increase from $2,262.957 million in 2021 to $2,557.868 million in 2025, indicating the company's expansion and investment in its operations. This growth in assets suggests that BIO-TECHNE Corp has been able to effectively deploy its resources to drive business development and potentially enhance its competitive position in the industry. Simultaneously, total liabilities have fluctuated slightly but remained within a manageable range, decreasing from $699.986 million in 2021 to $639.060 million in 2025. This reduction in liabilities relative to assets reflects a strengthening of the company's financial health and a lower debt burden, which can be positive indicators for investors and stakeholders. Stockholders' equity has also shown consistent growth, increasing from $1,562.971 million in 2021 to $1,918.808 million in 2025, signifying an improvement in the company's overall value and net worth. Overall, BIO-TECHNE Corp's financial position appears robust and demonstrates a sound balance between assets, liabilities, and equity. The company's strategic management of its resources has supported its growth and profitability over the years, positioning it well within the industry. The noteworthy fluctuations in liabilities and equity reflect the company's ability to navigate changing market conditions effectively while maintaining a strong financial foundation.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.